Liminatus Pharma LIMN
NASDAQ LIMN
$0.11 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Total Current Liabilities (2024 - 2026)

Liminatus Pharma (LIMN) posted Total Current Liabilities of $2.9 million for Q1 2026, down 71.94% sequentially from $10.3 million in Q4 2025.

Liminatus Pharma (LIMN) Total Current Liabilities (2024 - 2026) Analysis & Trends

Liminatus Pharma has reported Total Current Liabilities for 3 years, with the latest figure at $2.9 million in Q1 2026.

  • Quarterly Total Current Liabilities changed N/A year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at $10.3 million, down 58.39% from the prior year.
  • Total Current Liabilities retreated to $2.9 million in Q1 2026 per LIMN's latest filing, from $10.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $24.7 million in Q4 2024 and troughed at $2.9 million in Q3 2025.
  • A 3-year average of $10.3 million and a median of $10.3 million in 2025 frame the typical range for Total Current Liabilities.
  • The widest YoY moves for Total Current Liabilities: up 58.39% in 2025, down 58.39% in 2025.
  • Over 3 years, Total Current Liabilities stood at $24.7 million in 2024, then slumped by 58.39% to $10.3 million in 2025, then tumbled by 71.94% to $2.9 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $2.9 million, $10.3 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.58 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.51 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 438.74 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 630.93 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 2.49 Bn
10 Liminatus Pharma 5.46 Mn 5.46 Mn - 3.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.89 Mn
Dec 31, 2025 10.30 Mn
Sep 30, 2025 2.86 Mn
Jun 30, 2025 10.52 Mn
Dec 31, 2024 24.75 Mn